about
Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidenceThe Repeated Administration of Resveratrol Has Measurable Effects on Circulating T-Cell Subsets in Humans.Genetic variants of human granzyme B predict transplant outcomes after HLA matched unrelated bone marrow transplantation for myeloid malignancies.A genetic variant in the IL-17 promoter is functionally associated with acute graft-versus-host disease after unrelated bone marrow transplantation.Resveratrol induces cell cycle arrest and apoptosis in malignant NK cells via JAK2/STAT3 pathway inhibitionParaptosis cell death induction by the thiamine analog benfotiamine in leukemia cellsNKG2D gene polymorphism has a significant impact on transplant outcomes after HLA-fully-matched unrelated bone marrow transplantation for standard risk hematologic malignanciesA functional polymorphism in the NKG2D gene modulates NK-cell cytotoxicity and is associated with susceptibility to Human Papilloma Virus-related cancers.Induced pluripotent stem cell technology: A window for studying the pathogenesis of acquired aplastic anemia and possible applications.Microbe-Induced Inflammatory Signals Triggering Acquired Bone Marrow Failure Syndromes.Mycophenolic acid inhibits natural killer cell proliferation and cytotoxic function: a possible disadvantage of including mycophenolate mofetil in the graft-versus-host disease prophylaxis regimen.Autoantibodies specific to hnRNP K: a new diagnostic marker for immune pathophysiology in aplastic anemia.Anti-moesin antibodies derived from patients with aplastic anemia stimulate monocytic cells to secrete TNF-alpha through an ERK1/2-dependent pathway.Cyclosporine restores hematopoietic function by compensating for decreased Tregs in patients with pure red cell aplasia and acquired aplastic anemia.The recipient CCR5 variation predicts survival outcomes after bone marrow transplantation.Toll-like receptor genetic variations in bone marrow transplantation.Toll-like receptor 1 variation increases the risk of transplant-related mortality in hematologic malignancies.Epstein-Barr virus-associated leukemic lymphoma after allogeneic stem cell transplantation.A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation.Gastric microbiota: An emerging player in Helicobacter pylori-induced gastric malignancies.Synchronous Occurrence of Mycosis Fungoides, Diffuse Large B Cell Lymphoma and Acute Myeloid Leukemia.Erratum to: A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation.The simultaneous inhibition of the mTOR and MAPK pathways with Gnetin-C induces apoptosis in acute myeloid leukemia.An altered gut microbiota may trigger autoimmune-mediated acquired bone marrow failure syndromes.Machine learning for tackling microbiota data and infection complications in immunocompromised patients with cancer.Resveratrol selectively induces apoptosis in malignant cells with the JAK2V617F mutation by inhibiting the JAK2 pathway.The recipient CXCL10 +1642C>G variation predicts survival outcomes after HLA fully matched unrelated bone marrow transplantationNew Insights on the Pathogenesis of Takayasu Arteritis: Revisiting the Microbial TheoryClassic Hodgkin Lymphoproliferative Diseases Clonally Unrelated to B-Chronic Lymphocytic Leukemia Successfully Treated with Bendamustine Plus RituximabRecipient Single-Nucleotide Polymorphism Predicts Relapse after Unrelated Bone Marrow Transplantation for Hematologic MalignancyExcessive Reactive Iron Impairs Hematopoiesis by Affecting Both Immature Hematopoietic Cells and Stromal CellsMalaria Resurgence in the Americas: An Underestimated ThreatA single nucleotide polymorphism of IL-17 gene in the recipient is associated with acute GVHD after HLA-matched unrelated BMTA single-nucleotide polymorphism of the Fcγ receptor type IIIA gene in the recipient predicts transplant outcomes after HLA fully matched unrelated BMT for myeloid malignanciesHematopoiesis by iPSC-derived hematopoietic stem cells of aplastic anemia that escape cytotoxic T-cell attackEpstein-Barr Virus and Helicobacter Pylori Co-Infection in Non-Malignant Gastroduodenal DisordersDonor Heme Oxygenase-1 Promoter Gene Polymorphism Predicts Survival after Unrelated Bone Marrow Transplantation for High-Risk PatientsRationale for assessing the therapeutic potential of resveratrol in hematological malignanciesMultiple cytokine-producing B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classic Hodgkin lymphoma with autoimmune hemolytic anemiaInterleukin-17-producing angioimmunoblastic T-cell lymphoma with Evans syndrome
P50
Q26745552-0004C124-48ED-4993-AED8-AB643AAFEF09Q33701615-C3144810-5A81-4F91-9546-3270FD177C88Q34008970-607C5F79-A367-4027-A195-5B2F3A37848CQ34058468-98C7F026-DF17-44A9-B9B1-B16A38B3F29CQ34571639-2B3C4F77-45B9-43A8-B4CA-9A22DB97FF8BQ35596628-0A4D30D0-1EC1-4CFE-9C1D-DA15877F8294Q37369943-C3A42F67-256A-49A3-B65D-52C2DA052DF7Q37519488-24C8F0CF-D3F8-4451-8842-00F4FD63E919Q39071229-AD01B6E2-C365-48D2-8414-9AC13A994F30Q39175446-F74AC00C-D573-4852-A3BA-9868726D3D03Q39663828-7FA0C283-4EF3-4F5F-B386-5AAC94CF6E01Q39681580-BCD1B73A-35BD-45D2-AC70-864A28A8D088Q39833116-57DFFB41-6438-46EC-8011-82DC6F5165A5Q39927825-E86DBE10-FA4D-4B0D-AC1E-8F86C2C545BBQ40208593-CE9833A3-CDC5-4B74-9D1D-1CDC51219A7CQ40209654-7B6A2EAF-3473-4604-ADCB-7E69357DCA78Q40628153-2FE7A982-4489-4540-8A67-CAA9E812DB73Q40738850-BD3B0DBA-5A96-4A62-9066-67A248102FD2Q41070167-78E1CD41-E6C1-4B07-807B-82BC4A9314E7Q50017134-42963DCF-D6A8-45AD-B7DD-5412A08421ADQ50101634-5448E8B6-C9AF-4386-B9E5-8D40FBF687CBQ50437412-E65EDA44-3CF2-4EEA-84B3-C35BD393EA45Q50689601-8338D13E-778F-4F1E-B81A-0DF028683F38Q53805937-AD2F6217-E47C-4E49-8CE6-7555BB827489Q54252047-6328B268-95EF-4C16-926A-B204A2012930Q55042835-F8CF803E-44A8-4F4C-9698-048F6DF94DF2Q57918170-BDCADB96-184F-40B5-AF44-5186A51920F6Q58761058-C92B11BC-7D52-49A1-8B1F-5B5069A079AFQ58766568-52DE5516-6FE6-43FB-B66E-E60FF4992BEBQ60917069-7B4E63A9-57FB-4125-9E95-C82B4F8952F4Q64113730-0C5ABE58-0648-4C94-997C-87098BFDA481Q64230999-A6DC6BDF-F285-4541-B662-C9BE701B71A8Q83156114-007010C5-DB20-489A-833C-FA4CD885ABA1Q84074302-B9608CE2-2BE3-4196-A560-A4904D8AC16BQ87854899-4DB33AF2-6BE9-4C27-9207-DBA190F8E4F4Q89634346-17B41A69-2F39-4C31-A454-FC0352BDA8C3Q89719591-37346F8D-37F7-48A0-9FD3-D8B0E7F275E8Q90044281-FC21B1E6-8DE8-4F40-BF7C-34E2D90DC124Q90165156-F41DD708-68D1-4C55-A9A2-E4B69236CF01Q90788830-286F956E-6455-4711-9D88-B01EE9990164
P50
description
investigador
@es
researcher
@en
name
J Luis Espinoza
@en
type
label
J Luis Espinoza
@en
prefLabel
J Luis Espinoza
@en
P31
P496
0000-0002-1794-6666